-
Mashup Score: 8Ruxolitinib cream improves sleep disturbances, itch in children with atopic dermatitis - 1 month(s) ago
SAN DIEGO — Ruxolitinib cream improved quality of life outcomes, including sleep and itch, in children aged 2 to 11 years with atopic dermatitis, according to a poster presented at the American Academy of Dermatology Annual Meeting. As Healio previously reported, ruxolitinib cream, a topically administered selective Janus kinase 1 and 2 inhibitor, has proven to be an effective
Source: www.healio.comCategories: General Medicine News, Allergy-ImmunologyTweet
#Ruxolitinib cream shows promise in alleviating sleep disturbances and itchiness in children diagnosed with #atopic #dermatitis. Check out the latest findings! #dermatology #skincare https://t.co/vwpczVdlqJ https://t.co/GyT1ktGMyi